Annexon (ANNX) Depreciation and Depletion (2020 - 2024)
Annexon's (ANNX) quarterly Depreciation and Depletion came in at $500000.0 in Q3 2024, little changed year-on-year from $500000.0 in Q4 2023, and little changed quarter-over-quarter from $500000.0 in Q2 2024.
Annexon (ANNX) Depreciation and Depletion (2020 - 2024) Analysis & Trends
Annexon's Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $500000.0 for Q3 2024.
- On a quarterly basis, Depreciation and Depletion changed 0.0% year-over-year to $500000.0 in Q3 2024; TTM through Sep 2024 was $2.0 million, a 0.0% change from a year earlier, with the FY2023 full-year figure at $2.1 million, changed 0.0% from the prior year.
- Depreciation and Depletion was little changed at $500000.0 in Q3 2024 per ANNX's latest filing, from $500000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $600000.0 in Q3 2021 and bottomed at $100000.0 in Q3 2020.
- The 5-year median for Depreciation and Depletion is $500000.0 (2021), against an average of $470588.2.
- Across the five-year window, Depreciation and Depletion surged 500.0% in 2021 and declined 16.67% in 2022, its largest moves.
- Year by year, Depreciation and Depletion stood at $300000.0 in 2020, then jumped by 66.67% to $500000.0 in 2021, then changed by 0.0% to $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then changed by 0.0% to $500000.0 in 2024.
- Per Business Quant, the three latest ANNX Depreciation and Depletion figures stand at $500000.0 (Q3 2024), $500000.0 (Q2 2024), and $500000.0 (Q1 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 500,000.00 |
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 500,000.00 |
| Dec 31, 2022 | 500,000.00 |
| Sep 30, 2022 | 500,000.00 |
| Sep 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 500,000.00 |